{"title": [{"text": "Characterization of Divergence in Impaired Speech of ALS Patients", "labels": [], "entities": []}], "abstractContent": [{"text": "Approximately 80% to 95% of patients with Amyotrophic Lateral Sclerosis (ALS) eventually develop speech impairments (Beukelman et al., 2011), such as defective articulation, slow laborious speech and hy-pernasality (Duffy, 2013).", "labels": [], "entities": [{"text": "Amyotrophic Lateral Sclerosis (ALS)", "start_pos": 42, "end_pos": 77, "type": "TASK", "confidence": 0.76150215168794}]}, {"text": "The relationship between impaired speech and asymp-tomatic speech maybe seen as a divergence from a baseline.", "labels": [], "entities": []}, {"text": "This relationship can be characterized in terms of measurable combinations of phonological characteristics that are indicative of the degree to which the two diverge.", "labels": [], "entities": []}, {"text": "We demonstrate that divergence measurements based on phonological characteristics of speech correlate with physiological assessments of ALS.", "labels": [], "entities": []}, {"text": "Speech-based assessments offer benefits over commonly-used physiological assessments in that they are inexpensive , non-intrusive, and do not require trained clinical personnel for administering and interpreting the results.", "labels": [], "entities": []}], "introductionContent": [{"text": "Amyotrophic lateral sclerosis (ALS) or Lou Gehrig's Disease, the most common form of motor neuron disease, is a rapidly progressive, neurodegenerative condition.", "labels": [], "entities": [{"text": "Amyotrophic lateral sclerosis (ALS)", "start_pos": 0, "end_pos": 35, "type": "TASK", "confidence": 0.7448951303958893}]}, {"text": "It is characterized by muscle atrophy, muscle weakness, muscle spasticity, hyperreflexia, difficulty speaking (dysarthria), difficulty swallowing (dysphagia), and difficulty breathing (dyspnea).", "labels": [], "entities": []}, {"text": "Mean survival time for ALS patients is three to five years from the time it is diagnosed; however, death may occur within months, or survival may last decades.", "labels": [], "entities": [{"text": "survival time", "start_pos": 5, "end_pos": 18, "type": "METRIC", "confidence": 0.9595424830913544}]}, {"text": "Most physiological assessments used to determine the functional status of patients with ALS are invasive, involving the use of expensive equipment and requiring trained clinical personnel to administer the tests and interpret the results.", "labels": [], "entities": []}, {"text": "This is the case fora number of standardized objective assessments of bulbar function in ALS patients (, for example: breathing patterns, articulatory patterns, and voice loudness.", "labels": [], "entities": []}, {"text": "These are generally measured by technologies that record chest wall movements, oral pressures and flows, oral movement and strength, and speech acoustics.", "labels": [], "entities": []}, {"text": "This paper lays the foundation for the development of less invasive phonologically-inspired measures that correlate strongly with (more invasive) physiological measures of ALS.", "labels": [], "entities": []}, {"text": "Speech impairments eventually affect 80% to 95% of patients with ALS).", "labels": [], "entities": []}, {"text": "In fact, noted that speech impairments maybe present up to 33 months prior to diagnosis of ALS.", "labels": [], "entities": []}, {"text": "Several previous studies  have shown that speech impairments correlate with physiological changes associated with ALS.", "labels": [], "entities": []}, {"text": "Thus, we focus on correlating measures based on phonological features with standard physiological measures, thus enabling new, non-invasive measures for assessing the functionality of an ALS patient without significant overhead for personnel training and administration.", "labels": [], "entities": []}, {"text": "To bring this about, we determine the degree of divergence of symptomatic speech from asymptomatic speech taken as a baseline.", "labels": [], "entities": []}, {"text": "This determination is based on phonological features in speech, most of which have been previously identified in the literature as being associated with ALS, e.g., monoloudness, hypernasality and distorted vowels, see.", "labels": [], "entities": []}, {"text": "These are annotated, for the current study, by specialists, i.e., a phonolo-gist and a speech therapist experienced in working with ALS patients.", "labels": [], "entities": []}, {"text": "The degree of divergence is correlated with physiological assessments of ALS, namely %FVC (Forced Vital Capacity) in sitting (%FVC-SIT) as well as supine (%FVC-SUP) positions.", "labels": [], "entities": [{"text": "FVC (Forced Vital Capacity)", "start_pos": 86, "end_pos": 113, "type": "METRIC", "confidence": 0.8609254459540049}, {"text": "FVC-SIT", "start_pos": 127, "end_pos": 134, "type": "METRIC", "confidence": 0.8901053071022034}]}, {"text": "The rest of the paper is organized as follows: In Section 2 we discuss related work that motivates and informs our research.", "labels": [], "entities": []}, {"text": "Section 3 describes data used for our experiments.", "labels": [], "entities": []}, {"text": "A discussion of speech divergence is presented in Section 4.", "labels": [], "entities": [{"text": "speech divergence", "start_pos": 16, "end_pos": 33, "type": "TASK", "confidence": 0.751196563243866}]}, {"text": "Section 5 presents an assessment of the degree to which divergent characteristics in the speech match the level of progress of the ALS condition.", "labels": [], "entities": []}, {"text": "This is followed by a discussion of future work and conclusions in Section 6.", "labels": [], "entities": []}], "datasetContent": [], "tableCaptions": [{"text": " Table 3: Physiological Scores (%FVC) and Di- vergence Scores (D.S.) variant (d) for average of  all four utterances for ALS speakers. The feature  count was based on a union of features across the  two annotators. Total frequency and Likert scale  values were computed as a maximum across the  two annotators.", "labels": [], "entities": [{"text": "Di- vergence Scores (D.S.) variant (d)", "start_pos": 42, "end_pos": 80, "type": "METRIC", "confidence": 0.912945731119676}, {"text": "Likert scale", "start_pos": 235, "end_pos": 247, "type": "METRIC", "confidence": 0.9391062259674072}]}, {"text": " Table 4: Correlations between the Physiological  Scores (%FVC) and Divergence Scores (D.S.) for  all four variants", "labels": [], "entities": [{"text": "Physiological  Scores (%FVC)", "start_pos": 35, "end_pos": 63, "type": "METRIC", "confidence": 0.8243294715881347}, {"text": "Divergence Scores (D.S.)", "start_pos": 68, "end_pos": 92, "type": "METRIC", "confidence": 0.8223741173744201}]}, {"text": " Table 5: Correlations between the Physiological  Scores (%FVC) and Feature Count Based Diver- gence Scores (D.S.) for all four variants", "labels": [], "entities": [{"text": "Feature Count Based Diver- gence Scores (D.S.)", "start_pos": 68, "end_pos": 114, "type": "METRIC", "confidence": 0.9181603789329529}]}, {"text": " Table 6: Correlations between the Physiological  Scores (%FVC) and Feature Frequency Based Di- vergence Scores (D.S.) for all four variants", "labels": [], "entities": [{"text": "Physiological  Scores (%FVC)", "start_pos": 35, "end_pos": 63, "type": "METRIC", "confidence": 0.673026043176651}, {"text": "Feature Frequency Based Di- vergence Scores (D.S.)", "start_pos": 68, "end_pos": 118, "type": "METRIC", "confidence": 0.745772710442543}]}]}